Vernazza Stefania, Tirendi Sara, Bassi Anna Maria, Traverso Carlo Enrico, Saccà Sergio Claudio
IRCCS-Fondazione Bietti, via Livenza 3, 00198 Rome, Italy.
Department of Experimental Medicine (DIMES), University of Genoa, 16132 Genoa, Italy.
J Clin Med. 2020 Sep 30;9(10):3172. doi: 10.3390/jcm9103172.
Primary open-angle glaucoma (POAG) is the second leading cause of irreversible blindness worldwide. Increasing evidence suggests oxidative damage and immune response defects are key factors contributing to glaucoma onset. Indeed, both the failure of the trabecular meshwork tissue in the conventional outflow pathway and the neuroinflammation process, which drives the neurodegeneration, seem to be linked to the age-related over-production of free radicals (i.e., mitochondrial dysfunction) and to oxidative stress-linked immunostimulatory signaling. Several previous studies have described a wide range of oxidative stress-related makers which are found in glaucomatous patients, including low levels of antioxidant defences, dysfunction/activation of glial cells, the activation of the NF-κB pathway and the up-regulation of pro-inflammatory cytokines, and so on. However, the intraocular pressure is still currently the only risk factor modifiable by medication or glaucoma surgery. This present review aims to summarize the multiple cellular processes, which promote different risk factors in glaucoma including aging, oxidative stress, trabecular meshwork defects, glial activation response, neurodegenerative insults, and the altered regulation of immune response.
原发性开角型青光眼(POAG)是全球不可逆性失明的第二大主要原因。越来越多的证据表明,氧化损伤和免疫反应缺陷是导致青光眼发病的关键因素。事实上,传统房水流出途径中小梁网组织的功能障碍以及驱动神经退行性变的神经炎症过程,似乎都与年龄相关的自由基过度产生(即线粒体功能障碍)以及氧化应激相关的免疫刺激信号有关。此前的多项研究描述了青光眼患者体内发现的多种与氧化应激相关的标志物,包括抗氧化防御水平低下、胶质细胞功能障碍/激活、NF-κB通路激活以及促炎细胞因子上调等。然而,眼压目前仍是唯一可通过药物或青光眼手术进行调节的风险因素。本综述旨在总结多种细胞过程,这些过程会促成青光眼的不同风险因素,包括衰老、氧化应激、小梁网缺陷、胶质细胞激活反应、神经退行性损伤以及免疫反应调节异常。